PAVM — PAVmed Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2016-07-28.
Performance
Technicals
Others in Healthcare
Measured signals that fired on PAVM
| date | signal | measured base rate |
|---|---|---|
| 2026-03-31 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-03-26 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-04-02 | Agrawal Sundeep Director | Grant or award | 13.9K | 0.00 | 0 |
| 2026-04-02 | Aklog Lishan Chairman and CEO | Grant or award | 350.0K | 0.00 | 0 |
| 2026-04-02 | Baxter Timothy E Director | Grant or award | 13.9K | 0.00 | 0 |
| 2026-04-02 | Glennon Michael J Director | Grant or award | 13.9K | 0.00 | 0 |
| 2026-04-02 | Gordon Michael Adam General Counsel | Grant or award | 110.0K | 0.00 | 0 |
| 2026-04-02 | MCGRATH DENNIS M President and CFO | Grant or award | 180.0K | 0.00 | 0 |
| 2026-04-02 | O'Neil Shaun Chief Operating Officer | Grant or award | 110.0K | 0.00 | 0 |
| 2026-04-02 | Sparks Ronald M Director | Grant or award | 13.9K | 0.00 | 0 |
| 2026-04-02 | White Debra Director | Grant or award | 13.9K | 0.00 | 0 |
| 2026-04-02 | Lee Victoria Tou-ho Chief Medical Officer | Grant or award | 70.0K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Two Seas Capital LP | 4.7M | 461.5K |
| FIRST MANHATTAN CO. LLC. | 241.6K | 23.8K |
| GEODE CAPITAL MANAGEMENT, LLC | 119.5K | 11.8K |
| VANGUARD CAPITAL MANAGEMENT LLC | 60.1K | 5.9K |
| VANGUARD FIDUCIARY TRUST CO | 55.1K | 5.4K |
| BlackRock, Inc. | 24.5K | 2.4K |
| Tower Research Capital LLC (TRC) | 6.3K | 622 |
| MORGAN STANLEY | 1.7K | 165 |
| CWM, LLC | 1.6K | 157 |
| UBS Group AG | 760 | 75 |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Latest SEC filings
| form | filed | period | |
|---|---|---|---|
| 8-K | 2026-08-14 | 2026-08-14 | on EDGAR ↗ |
| SCHEDULE 13G/A | 2026-08-13 | — | on EDGAR ↗ |
| 10-Q | 2026-08-13 | 2026-06-30 | on EDGAR ↗ |
| S-8 | 2026-07-30 | — | on EDGAR ↗ |
| 8-K | 2026-06-24 | 2026-06-24 | on EDGAR ↗ |
| SCHEDULE 13G | 2026-05-15 | — | on EDGAR ↗ |
| 8-K | 2026-05-15 | 2026-05-15 | on EDGAR ↗ |
| 10-Q | 2026-05-14 | 2026-03-31 | on EDGAR ↗ |
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- PAVmed (PAVM) Q2 2026 Earnings Call Transcript · 2026-08-15
- PAVmed targets early 2027 Veris 510(k) submission while pursuing PortIO 510(k) pathway · 2026-08-14
- Pavmed Inc. (PAVM) filed form 8-K · 2026-08-14 · SEC EDGAR
- PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results · 2026-08-14
Ask the AI about PAVM
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →